Dr. Aagon Krishna Shrestha
Book an appointment for Consultation

Dr. Aagon Krishna Shrestha

Oncoplastic Breast Surgeon


Dr. Aagon Krishna Shrestha is an Oncoplastic Breast Surgeon at Nepal Mediciti Hospital, recognized for his comprehensive and compassionate approach to breast cancer treatment. With a strong foundation in general surgery and advanced training in breast onco-surgery, he is committed to delivering state-of-the-art care to patients battling breast cancer.

Dr. Shrestha earned his Master’s degree in General Surgery from Shanghai Jiao Tong University, China, and further honed his specialization through a fellowship in Breast Onco-surgery at TATA Medical Center, one of Asia’s leading institutions in cancer care. His training equips him with the latest techniques in both oncologic safety and aesthetic reconstruction—the hallmark of oncoplastic surgery.

He has a particular interest in young breast cancer patients and excels in reconstructive breast onco-surgeries, aiming to preserve both physical appearance and psychological well-being while ensuring optimal cancer control. Dr. Shrestha integrates the latest surgical advancements with individualized care plans to improve both clinical outcomes and quality of life for his patients.

A passionate advocate for breast cancer awareness and patient education, Dr. Shrestha actively works to enhance treatment methodologies through innovation and collaboration. His clinical excellence, coupled with a compassionate bedside manner, makes him a trusted leader in breast cancer surgery in Nepal.


Education

Area of Focus

  • Oncoplastic Breast Surgery

Language spoken

  • ENGLISH
  • NEPALI
  • HINDI
  • NEWARI
  • CHINESE

Fellowship in Breast Onco Surgery in TATA Medical Center in 2023

 Treatment of younger women with breast cancer and broadening awareness and education about breast cancer.

  1. Paper presentation on TRAM flap reconstruction in Immediate Breast Reconstruction after Mastectomy at 3rd NCHCON endorsed by ASCON
  2. Paper Presentation on Initial Experience in the use of Methylene Blue dye as a single technique in Early Breast Cancer for Sentinel Lymph node Biopsy at 14th SAARC Federation of Oncologist-Nepal SFOICC
  3. Metastatic Ovarian Carcinoma In Breast Cancer patients during Risk Reduction Salpingo-oophorectomy:Report of two cases- published in Annals of Medicine and Surgery- January 2022
  4. Primary dedifferentiated liposarcoma of Breast: A case report-published in Wiley’s in September 2022
  5. When do patients with Breast Cancer Seek Help from psycho-oncology services? A 3-year retrospective study from India- Indian Journal of Medicine and Pediatric Oncology in April 2023


 

Sign In  
Sign Up